title: The Home Infusion Therapy/Relative Benefit Index: summary of an analysis using insurance claims data.
abstract: OBJECTIVE
  The cost of providing services is the traditional criteria used by payers in making selective contracting decisions regarding home care providers in general, and home infusion therapy (HIT) vendors specifically for this analysis. This approach assumes comparable health outcomes, for which adequate measures often are unavailable. In practice, poor quality can result in a need for remedial services. The objective of this research is to develop a method to use health insurance claims data to incorporate the hidden costs of adverse outcomes into an analysis of the costs of a vendor's HIT.
  
  
  METHODS
  The Home Infusion Therapy/Relative Benefit Index (HIT/RBI) model incorporates measures of both the cost of providing HIT services as well as the cost of remedial treatment for the adverse outcomes that may result from HIT care, eg, emergency room visits. The data source for the analysis is the health care claims for a sample of managed care patients of national insurer for the period 1990 to 1994.
  
  
  RESULTS
  The analysis confirms that adverse clinical outcomes can lead to additional demand for remedial health care with resultant negative financial consequences. When the cost of the adverse outcomes is incorporated into the analysis, vendors who appeared to be low cost on the basis of HIT services, in fact were higher cost vendors, whereas vendors with a high cost of services but with few adverse events were low cost vendors.
  
  
  CONCLUSIONS
  Payers should consider both the clinical and economic consequences of providing care into account in selecting vendors. The HIT/RBI model is a useful tool for incorporating the cost of adverse outcomes into a comprehensive comparison of the cost multiple vendors of HIT services.
authors.affiliation: Analysis Group/Economics, Cambridge, Massachusetts 02138, USA.
authors.forename: H G
authors.initials: HG
authors.lastname: Birnbaum
authors.forename: M
authors.initials: M
authors.lastname: Tang
mesh_terms: D001424:Bacterial Infections / Q000191:economics / Q000209:etiology; D003362:Cost-Benefit Analysis; D017048:Health Care Costs; D006301:Health Services Needs and Demand / Q000706:statistics & numerical data; D018718:Home Infusion Therapy / Q000009:adverse effects / Q000191:economics* / Q000706:statistics & numerical data; D007345:Insurance Claim Review / Q000706:statistics & numerical data*; D008329:Managed Care Programs / Q000191:economics / Q000706:statistics & numerical data; D017063:Outcome Assessment, Health Care / Q000706:statistics & numerical data*; D015895:Relative Value Scales; D014481:United States